Glehen O - Search Results

1

Advances in the management of peritoneal malignancies.

Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O. Kepenekian V, et al. Among authors: glehen o. Nat Rev Clin Oncol. 2022 Nov;19(11):698-718. doi: 10.1038/s41571-022-00675-5. Epub 2022 Sep 7. Nat Rev Clin Oncol. 2022. PMID: 36071285 Review.

2

Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.

Glehen O, Mohamed F, Gilly FN. Glehen O, et al. Lancet Oncol. 2004 Apr;5(4):219-28. doi: 10.1016/S1470-2045(04)01425-1. Lancet Oncol. 2004. PMID: 15050953 Review.

3

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Glehen O, et al. J Clin Oncol. 2004 Aug 15;22(16):3284-92. doi: 10.1200/JCO.2004.10.012. J Clin Oncol. 2004. PMID: 15310771

4

Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients.

Cotte E, Glehen O, Mohamed F, Lamy F, Falandry C, Golfier F, Gilly FN. Cotte E, et al. Among authors: glehen o. World J Surg. 2007 Sep;31(9):1813-1820. doi: 10.1007/s00268-007-9146-8. World J Surg. 2007. PMID: 17629740

5

Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

Heudel P, Romestaing P, Barbet N, Falandry C, You B, Glehen O, Freyer G. Heudel P, et al. Among authors: glehen o. Clin Oncol (R Coll Radiol). 2008 Jun;20(5):369-74. doi: 10.1016/j.clon.2008.02.011. Epub 2008 Apr 11. Clin Oncol (R Coll Radiol). 2008. PMID: 18406583 Clinical Trial.

6

Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.

Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, Beaujard AC, Noel GF. Glehen O, et al. J Surg Oncol. 2008 Sep 15;98(4):242-6. doi: 10.1002/jso.21061. J Surg Oncol. 2008. PMID: 18726885 Review.

7

[Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy].

Passot G, Cotte E, Brigand C, Beaujard AC, Isaac S, Gilly FN, Glehen O. Passot G, et al. Among authors: glehen o. J Chir (Paris). 2008 Sep-Oct;145(5):447-53. doi: 10.1016/s0021-7697(08)74654-4. J Chir (Paris). 2008. PMID: 19106865 French.

8

Appraisal of peritoneal cavity's capacity in order to assess the pharmacology of liquid chemotherapy solution in hyperthermic intraperitoneal chemotherapy.

Duez A, Cotte E, Glehen O, Cotton F, Bakrin N. Duez A, et al. Among authors: glehen o. Surg Radiol Anat. 2009 Oct;31(8):573-8. doi: 10.1007/s00276-009-0483-1. Epub 2009 Mar 19. Surg Radiol Anat. 2009. PMID: 19296043

9

[Malignant primary peritoneal tumors].

Cotte E, Passot G, Isaac S, Gilly FN, Glehen O. Cotte E, et al. Among authors: glehen o. Presse Med. 2009 Dec;38(12):1814-22. doi: 10.1016/j.lpm.2008.10.025. Epub 2009 Apr 7. Presse Med. 2009. PMID: 19356892 Review. French.

10

Management of peritoneal carcinomatosis from colorectal cancer: current state of practice.

Cotte E, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O. Cotte E, et al. Among authors: glehen o. Cancer J. 2009 May-Jun;15(3):243-8. doi: 10.1097/PPO.0b013e3181a58d67. Cancer J. 2009. PMID: 19556911 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page